Novavax, Inc. announced a private placement to issue 6,500,000 common shares at an issue price of $13 per share for the gross proceeds of $84,500,000 on August 8, 2023. The transaction will include participation from new investor SK bioscience Co.,Ltd.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
57,400 KRW | -0.17% | 0.00% | -20.28% |
Mar. 28 | SK Bioscience Signs Deal with Sanofi for Five Vaccine Types | MT |
Mar. 07 | SK Bioscience Breaks Ground on Manufacturing Facility Expansion for Extending Product Pipeline | CI |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
57,400 KRW | -0.17% | 0.00% | 3.2B | ||
4.09 USD | +3.54% | +3.02% | 572M | ||
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.28% | 3.2B | |
-4.66% | 86.13B | |
+1.32% | 39.82B | |
-19.27% | 30.42B | |
+57.86% | 25.23B | |
-16.09% | 15.36B | |
-9.14% | 11.95B | |
-17.69% | 11.6B | |
-43.00% | 11.51B | |
+5.24% | 8.71B |
- Stock Market
- Equities
- A302440 Stock
- News SK bioscience Co.,Ltd.
- Novavax, Inc. announced that it expects to receive $84.5 million in funding from SK bioscience Co.,Ltd.